As of 2026-09-11, the Fair Value of Stoke Therapeutics Inc (STOK) is -16.69 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 29.34 USD, the upside of Stoke Therapeutics Inc is -156.89%.
With the market price of 29.34 USD and our fair value calculation, Stoke Therapeutics Inc (STOK) is not a good investment. Investing in STOK stocks now will result in a potential loss of 156.89%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -85.81 | -101.07 | -104.70 | -88.98 | -6.88 | -77.49 |
| YoY growth | -64.26% | -17.78% | -3.59% | 15.01% | 92.26% | 4.33% |
| Market Cap (mil) | 1,827.30 |
| P/E | |
| Forward P/E |
| EPS | -3.34 |
| Avg earnings growth rate | 4.33% |
| TTM earnings | -207.90 |